AN2 Therapeutics, Inc. (ANTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.07M | -5.24M | -6.38M | -7.6M | -10.62M | -5.27M | -12.01M | -14.38M | -17.59M | -17.07M | -11.8M | -12.82M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -13.64% | 0.7% | 46.91% | 47.17% | 39.61% | 69.11% | -1.75% | -12.16% | -51.72% | -123.46% | -24.38% | -33.65% |
| Net Income | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 414K | 0 | 0 |
| Stock-Based Compensation | 0 | 1.4M | 801K | 2M | 2.05M | 1.78M | 1.9M | 2.27M | 2.38M | 2.23M | 2.17M | 1.94M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.38M | -117K | -211K | -299K | -443K | -567K | -731K | -890K | -1.09M | -1.72M | -640K | -440K |
| Working Capital Changes | -3.42M | 2.19M | 2.39M | -2.84M | -1.58M | 1.04M | -431K | -1.33M | -2.27M | -1.1M | 3.38M | 1.48M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -405K | 795K | 113K | -960K | -244K | 1.61M | -174K | -548K | -243K | -2.11M | 1.65M | -414K |
| Cash from Investing | 8.29M | 7.17M | 6.11M | 5.83M | 9.19M | -6.88M | 18.72M | 16.46M | 26.29M | 420K | -62.46M | 7.88M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 37.33M | 0 | 48K | 0 | 65K | 0 | 23K | 0 | 349K | -321K | 66.07M | 19.05M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 37.33M | 0 | 48K | 0 | 65K | 0 | 23K | 0 | 349K | -321K | 65.8M | 19.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 266K | 0 |
| Net Change in Cash | 33.55M | 1.94M | -217K | -1.76M | -1.37M | -12.15M | 6.74M | 2.08M | 9.05M | -16.97M | -8.2M | 14.1M |
| Free Cash Flow | -12.07M | -5.24M | -6.38M | -7.6M | -10.62M | -5.27M | -12.01M | -14.38M | -17.59M | -17.07M | -11.8M | -12.82M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -13.64% | 0.7% | 46.91% | 47.17% | 39.61% | 69.11% | -1.75% | -12.16% | -51.72% | -123.46% | -24.38% | -33.65% |
| FCF per Share | -0.35 | -0.17 | -0.21 | -0.25 | -0.35 | -0.18 | -0.40 | -0.48 | -0.59 | -0.57 | -0.46 | -0.66 |
| FCF Conversion (FCF/Net Income) | 1.20x | 0.60x | 0.68x | 1.18x | 1.00x | 0.70x | 0.94x | 1.00x | 1.06x | 1.01x | 0.71x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |